{"id":"W2095704084","doi":"10.1056/nejmoa1111097","title":"Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":469,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Docetaxel; Capecitabine; Medicine; Gemcitabine; Bevacizumab; Chemotherapy; Internal medicine; Cyclophosphamide; Breast cancer; Metastatic breast cancer; Oncology; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009750405,0.0003296407,0.001395658,0.0004709874,0.0002006369,0.0005198662,0.0003761727,0.0005818673,0.003533437],"category_scores_gemma":[0.002232711,0.0002819462,0.00054128,0.0003776678,0.000474101,0.0002665467,0.0003452774,0.001487553,0.0004475993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007205884,"about_ca_system_score_gemma":0.0006755557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004586448,"about_ca_topic_score_gemma":0.001568977,"domain_scores_codex":[0.9991732,0.0004660612,0.00007653834,0.00007893458,0.0001437835,0.00006134605],"domain_scores_gemma":[0.9989479,0.0004324582,0.0002044417,0.00005561323,0.00005952692,0.0002999718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.68247,0.01351665,0.01526987,0.003028455,0.001850033,0.0005837121,0.0001728961,0.005341624,0.02809621,0.0005728901,0.002722271,0.2463754],"study_design_scores_gemma":[0.3620072,0.5596424,0.02659893,0.0007814876,0.002900558,0.00180154,0.00007833858,0.004714254,0.01523118,0.0007351734,0.025439,0.00007000247],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9784564,0.01361901,0.0006587881,0.0009449942,0.0009277599,0.001369855,0.0002079308,0.00005778372,0.003757499],"genre_scores_gemma":[0.9927234,0.003536023,0.001225064,0.0003568533,0.0003445217,0.0005935296,0.0002415855,0.000006180072,0.0009728358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003533437,"threshold_uncertainty_score":0.0118205,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02998680873924625,"score_gpt":0.3709373581257419,"score_spread":0.3409505493864956,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}